Results 101 to 110 of about 4,104 (188)

Case report: Exceptional transmission of congenital hyperinsulinism from a focal CHI mother to her diffuse CHI dichorionic diamniotic twins

Frontiers in Endocrinology
We present the case of a 36-year-old female who was diagnosed at birth with CHI that caused severe hypoglycaemia unresponsive to Diazoxide. Subtotal pancreatectomy was performed at the age of three weeks. Later, histological analysis of her pancreas in a
Daniela Telehuz, Oana Plesa, Florence Bouilloud, Helene Wucher, Pascale De Lonlay, Claire-Marine Bérat, Cécile Saint-Martin, Olivier Dupuy, Jean-Baptiste Arnoux   +8 more
doaj   +1 more source

Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers [PDF]

, 2013
Robert R. Henry, Theodore P. Ciaraldi, Debra Armstrong, P. Burke, Monica Ligueros‐Saylan, Sunder Mudaliar   +5 more
openalex   +1 more source

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Journal of Hepatocellular Carcinoma, 2018
Lynn G Feun,¹ Medhi Wangpaichitr,² Ying-Ying Li,¹ Deukwoo Kwon,³ Stephen P Richman,¹ Peter J Hosein,¹ Niramol Savaraj¹,² ¹Department of Medicine, Medical Oncology, Sylvester Comprehensive Cancer Center ...
Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N   +6 more
doaj  

Monitoring Patient Improvement Parameters following Pasireotide Treatment in Cushing’s Disease [PDF]

, 2013
Chris G. Yedinak, Jessica Brzana, Maria Fleseriu   +2 more
openalex   +1 more source

Long‐term efficacy and safety of once‐monthly pasireotide in Cushing's disease: A Phase III extension study [PDF]

, 2019
Maria Fleseriu, Stephan Petersenn, Beverly M. K. Biller, Pınar Kadıoğlu, Christophe De Block, Guy T’Sjoen, Marie‐Christine Vantyghem, Libuse Tauchmanovà, Judi Wojna, Sy Ha, André Lacroix, John Newell‐Price   +11 more
openalex   +1 more source

Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study [PDF]

, 2021
Susan L. Samson, Feng Gu, Ulla Feldt‐Rasmussen, Shao‐Ling Zhang, Yerong Yu, Przemysław Witek, Pramila Kalra, Alberto M Pedroncelli, Philippe Pultar, Nadine Jabbour, Michaela Paul, Marek Bolanowski   +11 more
openalex   +1 more source

Acromegaly treatment and bone: a bidirectional relationship. [PDF]

Pituitary
Chiloiro S, Palumbo C, Giampietro A, De Marinis L, Bianchi A, Giustina A, Pontecorvi A.   +6 more
europepmc   +1 more source

Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? [PDF]

Pituitary
Agrawal N, Mehta S, Feelders RA, Skwiersky S, Campana C, Dogan F, van Koetsveld PM, Neggers SJCMM, Wright K, Kim H, Zagzag D, Hofland LJ.   +11 more
europepmc   +1 more source

Cushing’s disease: is pasireotide LAR a breakthrough in adjuvant therapy after unsuccessful surgery?

, 2017
Przemysław Witek, Marta Mazur, Joanna Witek   +2 more
openalex   +1 more source

Case Report: Bilateral lens dislocation as an atypical presentation of acromegaly and review of the ocular effects of GH/IGF-1 excess. [PDF]

Front Endocrinol (Lausanne)
Vitale L, Fatti LM, Bonomi M, Frara S, Vitale G, Persani L, Cangiano B.   +6 more
europepmc   +1 more source